Warriner was diagnosed with multiple myeloma in 2006 and, after induction chemotherapy, underwent autologous stem cell transplantation at MD Anderson. He eloquently shared his story at the colloquium and will soon present his experiences to a panel at the National Cancer Institute. Immediate and late effects of symptoms and toxicities of cancer treatment can cause great distress to patients, limiting their functioning during and after treatment, and sometimes causing premature termination of treatment or reductions in dose. Therapy-related toxicities also can limit the development of new treatment options. As a step toward addressing these issues, we convened a working panel in March 2011 at a colloquium that included stakeholders in cancer research, industry, regulatory agencies and advocacy groups. The participants came together in Houston to identify the challenges that have prevented progress in reducing treatment-related symptom burden. We also developed a list of strategic steps to address these challenges, and identified stakeholders and agencies that could implement them.
Questions about Cancer Treatment Side Effect Research
Want more info about Cancer Treatment Side Effect Research?
Get free advice from education experts and Noodle community members.